The Cancer Biology Graduate Program is affiliated with the Training Program in Cancer Biology T32 award from the National Cancer Institute (NCI). With the help of the University of Colorado Cancer Center, the T32 funds 5 predoctoral students each year.
Lab: Nassour
Research: Role of Autophagy in Cell Death and Immortalization
Lab: Sherbenou
Research: My research aims to study mechanisms of chimeric antigen receptor (CAR) T cell therapy resistance in multiple myeloma. Specifically, I am interested in identifying a novel mechanism of BCMA antigenic escape and determining how prior anti-myeloma therapies impact CAR T cell function.
Lab: Bitler
Research: Investigating the Mediators of Viral Mimicry in EHMTi-Treated HGSC
Lab: Pietras
Research: Impact of protein synthesis and inflammation on the metabolism of myelodysplastic syndrome stem cells
Lars Wick
Lab: Zhao
Research: I study the oncogenic roles of MYC in tumorigenesis and progression, and aim to discover and/or develop novel targeted therapeutic strategies for treating MYC-driven cancers.